Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Mar-22 7:06 PM View:  | Mitchell Shawnte EVP, GC & Secretary | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 605 | -- | -- | (100%) 0.6K to 0 | |
| 09-Mar-22 7:19 PM View: | Smith Michael P EVP, CFO & Treasurer | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 8,016 | -- | -- | (100%) 8.02K to 0 | |
| 09-Mar-22 7:16 PM View: | Breitmeyer James B Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 1,250 | -- | -- | (100%) 1.25K to 0 | |
| 09-Mar-22 7:06 PM View: | Garner Cam L Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 81,843 | -- | -- | (100%) 81.84K to 0 | |
| 09-Mar-22 7:09 PM View: | Mast Erle T Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 3,027 | -- | -- | (100%) 3.03K to 0 | |
| 09-Mar-22 7:02 PM View: | Sagrolikar Ashish M EVP & Chief Operating Officer | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 17,156 | -- | -- | (100%) 17.16K to 0 | |
| 09-Mar-22 7:15 PM View: | Wiggins Mark C Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 2,500 | -- | -- | (100%) 2.5K to 0 | |
| 09-Mar-22 7:08 PM View: | Galer Bradley S. EVP & Chief Medical Officer | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 25,022 | -- | -- | (100%) 25.02K to 0 | |
| 09-Mar-22 7:04 PM View: | Farr Stephen J President & CEO Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 92,806 | -- | -- | (100%) 92.81K to 0 | |
| 09-Mar-22 7:10 PM View: | Farfel Gail M See Remarks | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 16,606 | -- | -- | (100%) 16.61K to 0 | |
| 09-Mar-22 7:11 PM View: | Tannenbaum Renee P Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 32,567 | -- | -- | (100%) 32.57K to 0 | |
| 09-Mar-22 7:03 PM View: | Waynick Denelle J Director | Zogenix, Inc. (ZGNX) | 07-Mar-22 | Disposition (change in control) | 584 | -- | -- | (100%) 0.58K to 0 | |
| 03-Feb-22 10:00 PM View: | Mast Erle T Director | Zogenix, Inc. (ZGNX) | 01-Feb-22 | Option Exercise | 1,250 | $12.00 | $15,000.00 | 41% 3.03K to 4.28K | |
| 03-Feb-22 10:00 PM View: | Mast Erle T Director | Zogenix, Inc. (ZGNX) | 01-Feb-22 | Planned Option Sale | 1,250 | $26.04 | $32,544.50 | (29%) 4.28K to 3.03K | |
| 21-Jan-22 9:23 PM View: | Mast Erle T Director | Zogenix, Inc. (ZGNX) | 19-Jan-22 | Option Exercise | 15,000 | $14.11 | $211,600.00 | 496% 3.03K to 18.03K | |
| 21-Jan-22 9:23 PM View: | Mast Erle T Director | Zogenix, Inc. (ZGNX) | 19-Jan-22 | Planned Option Sale | 15,000 | $26.09 | $391,296.00 | (83%) 18.03K to 3.03K | |
| 30-Nov-21 9:55 PM View: | Tannenbaum Renee P Director | Zogenix, Inc. (ZGNX) | 29-Nov-21 | Market Sale | 5,305 | $11.72 | $62,174.60 | (14%) 37.87K to 32.57K | 3% |
| 12-Aug-21 9:06 PM View: | Garner Cam L Director | Zogenix, Inc. (ZGNX) | 10-Aug-21 | Market Purchase | 10,000 | $14.83 | $148,298.00 | 14% 71.84K to 81.84K | (9%) |
| 06-Jul-21 10:00 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 02-Jul-21 | Payment of Exercise | 1,114 | $17.74 | $19,762.40 | (6%) 17.26K to 16.14K | |
| 06-Jul-21 10:00 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 02-Jul-21 | Option Exercise | 3,500 | -- | -- | 25% 13.76K to 17.26K | |
| 03-Jun-21 7:20 PM View: | Tannenbaum Renee P Director | Zogenix, Inc. (ZGNX) | 01-Jun-21 | Market Purchase | 5,000 | $17.05 | $85,247.50 | 15% 32.87K to 37.87K | < 1% |
| 03-Jun-21 7:20 PM View: | Waynick Denelle J Director | Zogenix, Inc. (ZGNX) | 01-Jun-21 | Market Purchase | 584 | $17.07 | $9,968.88 | 100% 0 to 0.58K | < 1% |
| 12-May-21 8:00 PM View: | Garner Cam L Director | Zogenix, Inc. (ZGNX) | 10-May-21 | Market Purchase | 15,000 | $19.03 | $285,496.00 | 94% 16.0K to 31.0K | (2%) |
| 17-Mar-21 4:03 PM View: | Smith Michael P EVP, CFO, Treasurer & Sec. | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Payment of Exercise | 1,806 | $20.70 | $37,384.20 | (20%) 8.83K to 7.02K | |
| 17-Mar-21 4:02 PM View: | Farfel Gail M EVP/Chief Development Officer | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Option Exercise | 5,156 | -- | -- | 45% 11.48K to 16.64K | |
| 17-Mar-21 4:04 PM View: | Galer Bradley S. EVP/Chief Medical Officer | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Option Exercise | 5,218 | -- | -- | 29% 18.05K to 23.27K | |
| 17-Mar-21 4:02 PM View: | Farfel Gail M EVP/Chief Development Officer | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Payment of Exercise | 1,864 | $20.70 | $38,584.80 | (11%) 16.64K to 14.78K | |
| 17-Mar-21 4:03 PM View: | Smith Michael P EVP, CFO, Treasurer & Sec. | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Option Exercise | 5,218 | -- | -- | 145% 3.61K to 8.83K | |
| 17-Mar-21 4:02 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Option Exercise | 4,531 | -- | -- | 47% 9.56K to 14.09K | |
| 17-Mar-21 4:03 PM View: | Farr Stephen J President and CEO Director | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Option Exercise | 16,875 | -- | -- | 21% 79.8K to 96.67K | |
| 17-Mar-21 4:02 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Payment of Exercise | 1,347 | $20.70 | $27,882.90 | (10%) 14.09K to 12.74K | |
| 17-Mar-21 4:04 PM View: | Galer Bradley S. EVP/Chief Medical Officer | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Payment of Exercise | 1,462 | $20.70 | $30,263.40 | (6%) 23.27K to 21.8K | |
| 17-Mar-21 4:03 PM View: | Farr Stephen J President and CEO Director | Zogenix, Inc. (ZGNX) | 15-Mar-21 | Payment of Exercise | 5,836 | $20.70 | $120,805.00 | (6%) 96.67K to 90.83K | |
| 20-Nov-20 5:15 PM View: | Garner Cam L Director | Zogenix, Inc. (ZGNX) | 19-Nov-20 | Market Purchase | 8,000 | $20.13 | $161,042.00 | 16% 48.84K to 56.84K | 5% |
| 18-Nov-20 5:05 PM View: | Tannenbaum Renee P Director | Zogenix, Inc. (ZGNX) | 17-Nov-20 | Market Sale | 15,000 | $20.74 | $311,066.00 | (31%) 47.87K to 32.87K | (2%) |
| 06-Jul-20 4:37 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 02-Jul-20 | Option Exercise | 3,750 | -- | -- | 58% 6.48K to 10.23K | |
| 06-Jul-20 4:37 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 02-Jul-20 | Payment of Exercise | 1,114 | $29.19 | $32,517.70 | (11%) 10.23K to 9.12K | 27% |
| 29-Jun-20 9:54 PM View: | Farfel Gail M EVP/Chief Development Officer | Zogenix, Inc. (ZGNX) | 25-Jun-20 | Payment of Exercise | 3,044 | -- | -- | (21%) 14.22K to 11.18K | |
| 30-Jun-20 10:00 PM View: | Farr Stephen J President and CEO Director | Zogenix, Inc. (ZGNX) | 25-Jun-20 | Option Exercise | 27,500 | -- | -- | 42% 65.86K to 93.36K | |
| 30-Jun-20 10:00 PM View: | Galer Bradley S. EVP/Chief Medical Officer | Zogenix, Inc. (ZGNX) | 25-Jun-20 | Payment of Exercise | 2,813 | $28.12 | $79,101.60 | (14%) 20.02K to 17.2K | 25% |
| 30-Jun-20 10:00 PM View: | Farr Stephen J President and CEO Director | Zogenix, Inc. (ZGNX) | 25-Jun-20 | Payment of Exercise | 13,635 | $28.12 | $383,416.00 | (15%) 93.36K to 79.72K | 25% |
| 29-Jun-20 9:54 PM View: | Farfel Gail M EVP/Chief Development Officer | Zogenix, Inc. (ZGNX) | 25-Jun-20 | Option Exercise | 8,750 | -- | -- | 160% 5.47K to 14.22K | |
| 30-Jun-20 10:00 PM View: | Galer Bradley S. EVP/Chief Medical Officer | Zogenix, Inc. (ZGNX) | 25-Jun-20 | Option Exercise | 10,000 | -- | -- | 100% 10.02K to 20.02K | |
| 13-May-20 5:39 PM View: | Farfel Gail M EVP/Chief Development Officer | Zogenix, Inc. (ZGNX) | 12-May-20 | Market Sale (Planned) | 2,573 | $28.21 | $72,584.30 | (34%) 7.62K to 5.05K | 25% |
| 11-May-20 6:18 PM View: | Sagrolikar Ashish M EVP & CHIEF COMMERCIAL OFFICER | Zogenix, Inc. (ZGNX) | 08-May-20 | Market Purchase | 1,000 | $25.45 | $25,450.00 | 20% 4.91K to 5.91K | (17%) |
| 24-Mar-20 4:38 PM View: | Wiggins Mark C Director | Zogenix, Inc. (ZGNX) | 23-Mar-20 | Market Purchase | 2,500 | $20.48 | $51,196.00 | 100% 0 to 2.5K | 4% |
| 20-Mar-20 4:01 PM View: | Farr Stephen J President and CEO Director | Zogenix, Inc. (ZGNX) | 19-Mar-20 | Option Exercise | 9,661 | $10.35 | $99,991.40 | 16% 61.75K to 71.41K | |
| 20-Mar-20 4:01 PM View: | Farr Stephen J President and CEO Director | Zogenix, Inc. (ZGNX) | 19-Mar-20 | Market Option Sale (Planned) | 6,158 | $18.51 | $113,964.00 | (9%) 71.41K to 65.25K | (15%) |
| 20-Mar-20 4:01 PM View: | Galer Bradley S. EVP/Chief Medical Officer | Zogenix, Inc. (ZGNX) | 18-Mar-20 | Market Purchase | 1,000 | $19.68 | $19,685.00 | 11% 9.02K to 10.02K | 8% |
| 17-Mar-20 7:24 PM View: | Smith Michael P EVP, CFO, Treasurer & Sec. | Zogenix, Inc. (ZGNX) | 15-Mar-20 | Option Exercise | 3,595 | -- | -- | 259% 1.39K to 4.98K |
